Roger Baxter

10.4k citations

136 papers · 7.1k indexed · 2 hit papers · h-index 45

Impact in

Microbiology top 0.1%
- Bacterial Infections and Vaccines
Health top 0.5%
- Vaccine Coverage and Hesitancy

Papers in ⓘ

Microbiology 39
- Bacterial Infections and Vaccines 37
Health 33
- Vaccine Coverage and Hesitancy 33

Co-authors: Bruce Fireman (43 shared papers)Nicola P. Klein (54 shared papers)G. Thomas Ray (9 shared papers)Joan Bartlett (12 shared papers)Edwin Lewis (22 shared papers)Ali Rowhani‐Rahbar (9 shared papers)Allison L. Naleway (30 shared papers)Eric Weintraub (24 shared papers)
Journals: Vaccine (32 papers)PEDIATRICS (19 papers)Clinical Infectious Diseases (7 papers)Open Forum Infectious Diseases (7 papers)American Journal of Epidemiology (7 papers)
Partner nations: United States Belgium Uganda

In The Last Decade

Roger Baxter

136 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children 2012 · 408 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 New England Journal of Medicine
2010 New England Journal of Medicine

Peers

Countries citing papers authored by Roger Baxter

Since Specialization

Citations

This map shows the geographic impact of Roger Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Baxter more than expected).

Fields of papers citing papers by Roger Baxter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Baxter. The network helps show where Roger Baxter may publish in the future.

Co-authors

The 25 scholars most cited alongside Roger Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger Baxter Line = papers co-authored together Roger Baxter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treatment with Monoclonal Antibodies against Clostridium difficile Toxins New England Journal of Medicine ·Israel Lowy, Deborah C. Molrine, Brett Leav, Barbra M. Blair, Roger Baxter, Dale N. Gerding, Geoffrey Nichol, William D. Thomas, Mark D. Leney, Susan Sloan, Catherine A. Hay, Donna M. Ambrosino Hit paper breakdown →	2010	557
2	Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children New England Journal of Medicine ·Nicola P. Klein, Joan Bartlett, Ali Rowhani‐Rahbar, Bruce Fireman, Roger Baxter Hit paper breakdown →	2012	408
3	The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety PEDIATRICS ·James Baggs, Julianne Gee, Edwin Lewis, Gabrielle Fowler, Patti Benson, Tracy A. Lieu, Allison L. Naleway, Nicola P. Klein, Roger Baxter, Edward A. Belongia, Jason M. Glanz, Simon J. Hambidge, Steven J. Jacobsen, Lisa A. Jackson, James D. Nordin, Eric Weintraub	2011	275
4	Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser Permanente The Pediatric Infectious Disease Journal ·Steven Black, Henry R. Shinefield, Roger Baxter, Robert Austrian, Laura Bracken, John Hansen, Edwin Lewis, Bruce Fireman	2004	245
5	Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures PEDIATRICS ·Nicola P. Klein, Bruce Fireman, W. Katherine Yih, Edwin Lewis, Martin Kulldorff, Paula Ray, Roger Baxter, Simon J. Hambidge, James D. Nordin, Allison L. Naleway, Edward A. Belongia, Tracy A. Lieu, James Baggs, Eric Weintraub, (unknown)	2010	215
6	Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study BMC Infectious Diseases ·G. Thomas Ray, Jose A Suaya, Roger Baxter	2013	207
7	Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI) Vaccine ·Brett Leav, Barbra M. Blair, Mark D. Leney, Michael Knauber, Courtney Reilly, Israel Lowy, Dale N. Gerding, Ciarán P. Kelly, Kia Katchar, Roger Baxter, Donna M. Ambrosino, Deborah C. Molrine	2009	193
8	Mycobacterial diseases and antitumour necrosis factor therapy in USA Annals of the Rheumatic Diseases ·K.L. Winthrop, Roger Baxter, L Liu, C.D. Varley, JR Curtis, J.W. Baddley, Bentson H. McFarland, Dan E. Austin, LeAnn Radcliffe, EB Suhler, Dongseok Choi, JT Rosenbaum, LJ Herrinton	2012	188
9	Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis PEDIATRICS ·Roger Baxter, Joan Bartlett, Bruce Fireman, Edwin Lewis, Nicola P. Klein	2017	176
10	The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety Vaccine ·Michael M. McNeil, Julianne Gee, Eric Weintraub, Edward A. Belongia, Grace M. Lee, Jason M. Glanz, James D. Nordin, Nicola P. Klein, Roger Baxter, Allison L. Naleway, Lisa A. Jackson, Saad B. Omer, Steven J. Jacobsen, Frank DeStefano	2014	166
11	Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias American Journal of Epidemiology ·Bruce Fireman, Janelle Lee, Ned Lewis, Oliver Bembom, Mark van der Laan, Roger Baxter	2009	161
12	Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers PEDIATRICS ·Nicola P. Klein, Joan Bartlett, Bruce Fireman, Ali Rowhani‐Rahbar, Roger Baxter	2013	145
13	Changing Epidemiology of Outpatient Bacteremia in 3- to 36-Month-Old Children After the Introduction of the Heptavalent-Conjugated Pneumococcal Vaccine The Pediatric Infectious Disease Journal ·Arnd M. Herz, Tara L. Greenhow, Jay Alcantara, John Hansen, Roger Baxter, Steve Black, Henry R. Shinefield	2006	137
14	Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized Patients Infection Control and Hospital Epidemiology ·Roger Baxter, G. Thomas Ray, Bruce Fireman	2007	124
15	Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection Blood ·Sarah Browne, Rifat Zaman, Elizabeth P. Sampaio, Kamonwan Jutivorakool, Lindsey B. Rosen, Li Ding, Minjal J. Pancholi, Lauren M. Yang, Debra Long Priel, Gülbû Uzel, Alexandra F. Freeman, Carlton E. Hayes, Roger Baxter, Stuart H. Cohen, Steven M. Holland	2012	124
16	Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies Vaccine ·Nicola P. Klein, Paula Ray, Diane M. Carpenter, John Hansen, Edwin Lewis, Bruce Fireman, Steven Black, Claudia Martins Galindo, Johannes Schmidt, Roger Baxter	2009	102
17	Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project American Journal of Epidemiology ·Sharon K. Greene, Martin Kulldorff, Edwin Lewis, Rong Li, Ruihua Yin, Eric Weintraub, Bruce Fireman, Tracy A. Lieu, James D. Nordin, Jason M. Glanz, Roger Baxter, Steven J. Jacobsen, Karen R. Broder, Grace M. Lee	2009	101
18	H1N1 and Seasonal Influenza Vaccine Safety in the Vaccine Safety Datalink Project American Journal of Preventive Medicine ·Grace M. Lee, Sharon K. Greene, Eric Weintraub, James Baggs, Martin Kulldorff, Bruce Fireman, Roger Baxter, Steven J. Jacobsen, Stephanie A. Irving, Matthew F. Daley, Ruihua Yin, Allison L. Naleway, James D. Nordin, Lingling Li, Natalie McCarthy, Claudia Vellozzi, Frank DeStefano, Tracy A. Lieu	2011	101
19	Air Pollution and Pulmonary Tuberculosis: A Nested Case–Control Study among Members of a Northern California Health Plan Environmental Health Perspectives ·Geneé S. Smith, Stephen K. Van Den Eeden, Cynthia Garcia, Jun Shan, Roger Baxter, Amy H. Herring, David B. Richardson, Annelies Van Rie, Michael Emch, Marilie D. Gammon	2016	99
20	Waning Tdap Effectiveness in Adolescents PEDIATRICS ·Nicola P. Klein, Joan Bartlett, Bruce Fireman, Roger Baxter	2016	97

About Roger Baxter

Roger Baxter is a scholar working on Microbiology, Health, Epidemiology, Infectious Diseases and Modeling and Simulation, having authored 136 papers that have together received 7.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (58 papers), Bacterial Infections and Vaccines (37 papers), Vaccine Coverage and Hesitancy (33 papers), Pneumonia and Respiratory Infections (24 papers), Respiratory viral infections research (23 papers), SARS-CoV-2 and COVID-19 Research (21 papers), Herpesvirus Infections and Treatments (14 papers) and Peripheral Neuropathies and Disorders (11 papers). The work is most often cited by research in Microbiology (1.9k citations), Health (1.2k citations), Infectious Diseases (2.6k citations), Epidemiology (4.6k citations) and Toxicology (169 citations). Roger Baxter has collaborated with scholars based in United States, Belgium and Uganda. Frequent co-authors include Bruce Fireman, Nicola P. Klein, G. Thomas Ray, Joan Bartlett, Edwin Lewis, Ali Rowhani‐Rahbar, Allison L. Naleway, Eric Weintraub, John Hansen and James D. Nordin. Their work appears in journals such as Vaccine, PEDIATRICS, Clinical Infectious Diseases, Open Forum Infectious Diseases and American Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact